United Therapeutics Corp. (UTHR)
510.76
-4.70
(-0.91%)
USD |
NASDAQ |
Aug 31, 16:00
510.76
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Cash from Operations (TTM) : 1.682B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.682B |
| March 31, 2026 | 1.563B |
| December 31, 2025 | 1.561B |
| September 30, 2025 | 1.556B |
| June 30, 2025 | 1.369B |
| March 31, 2025 | 1.409B |
| December 31, 2024 | 1.324B |
| September 30, 2024 | 1.137B |
| June 30, 2024 | 1.108B |
| March 31, 2024 | 982.40M |
| December 31, 2023 | 978.00M |
| September 30, 2023 | 945.30M |
| June 30, 2023 | 857.70M |
| March 31, 2023 | 878.40M |
| December 31, 2022 | 795.00M |
| September 30, 2022 | 848.90M |
| June 30, 2022 | 775.90M |
| March 31, 2022 | 797.10M |
| December 31, 2021 | 598.20M |
| September 30, 2021 | 548.10M |
| June 30, 2021 | 613.40M |
| March 31, 2021 | 629.20M |
| December 31, 2020 | 754.00M |
| September 30, 2020 | 732.00M |
| June 30, 2020 | 666.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 635.40M |
| December 31, 2019 | -206.60M |
| September 30, 2019 | -190.70M |
| June 30, 2019 | -171.60M |
| March 31, 2019 | -124.70M |
| December 31, 2018 | 778.40M |
| September 30, 2018 | 574.20M |
| June 30, 2018 | 628.20M |
| March 31, 2018 | 519.10M |
| December 31, 2017 | 474.20M |
| September 30, 2017 | 723.40M |
| June 30, 2017 | 693.60M |
| March 31, 2017 | 748.60M |
| December 31, 2016 | 643.60M |
| September 30, 2016 | 505.72M |
| June 30, 2016 | 484.33M |
| March 31, 2016 | 399.61M |
| December 31, 2015 | 382.76M |
| September 30, 2015 | 447.85M |
| June 30, 2015 | 449.08M |
| March 31, 2015 | 353.61M |
| December 31, 2014 | 355.26M |
| September 30, 2014 | 369.08M |
| June 30, 2014 | 299.84M |
| March 31, 2014 | 438.17M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Liquidia Corp. | 167.71M |
| MannKind Corp. | -8.217M |
| Vertex Pharmaceuticals, Inc. | 4.293B |
| Savara, Inc. | -110.38M |
| Exelixis, Inc. | 1.183B |